We seasonal earnings flow, historical reaffirming compared line all our share earnings and per and are expectations, Thank you. BWXT to we cash performance This delivered you, per $X.XX. we remarkably revenue revenue to good afternoon, results. mid-single-digit adjusted the X% adjusted X% and growth, share year and Chase, organic evening for growth in patterns. of adjusted Operating to of $X.XX calling leading reported growth EBITDA to quarter good full with our was guidance, first
into our plant, North spend like discussion, segment few minutes heavy nuclear the a largest America's on get I'd which facility. I recent Before expand the to already announcement to Cambridge is manufacturing equipment
in of for project the increase commercial manufacturing reactors it in potential and $XXX we extensions of builds by markets footprint and forward existing is this the commercial small moving Cambridge equipment. and nuclear and market. upgrade backlog to As CANDU demand facility with a for are demand incipient we robust With our and on advanced modular the recent reactors. new with life million, with discussed new ongoing over tangible future the large XX% calls, nuclear demand The Canada international
completion in will quarter years, this mid-XXXX. X planned next we the third million invest of starting year construction $XX in and the about Over with
would Microreactors is in investment signal projects. of exciting Supply energy that capacity and customers they enables more the Propulsion, BWRX-XXX ahead supply recent business just and is Vernova in clean the I execution enables as more new this the compete vein, expanded and Medical projects, company get add precipitating with qualified our This strength and growth much intention efficient that is backlog smaller existing Naval also GE and first did to just years. for we market demand our that of our last chain BWXT while the we know secure that Group. in to room announced week, for as Chain scale, In
and standards credentials require delivery on-time products that market-leading making we the high-quality meaningful be right ready at meet time investments customers with to Our satisfy with now, demand the extremely by will capacity.
discussions engaged value this others making in to couple with investment, visiting appropriate Before be road personally customers of top the to for generate with over next commitment our to returns provide. underscore our and months, the need industry we and the BWXT's will I'm on the
an occupy world-class and enviable qualifications. position experiential will workforce As BWXT given capacity inevitably tightens, its facilities
of segment market to results turning discussion the Now a outlook. and
a Government the in demand like growth a X% perspective, nicely Operations grow areas. From touch to I organic continue to quarter. with on would of revenue couple key
programs appropriations high delayed across provided a good XXXX fiscal our the and Government long Operations. at First, funding level, all
plan sustain industrial the The for request year fiscal base the and namely Program and prioritizes modernization this Looking shipbuilding the themes, President's 'XX Competition prepare underpin supports Submarine substantial BWXT's long-term Great Class office. secular growth the the and budget of in story. Power Decarbonization year, Columbia provide that beyond Global the submarine to investment
and energy, President. The in including billion the was investments which just supports This advanced clean and technology growth in ] signed in and is funds] the markets. bill supplemental $X.X 'XX in [fully specifically, a DARPA Defense [ complex the was at the which in thermal micro nuclear Dreco rocket engine for space, More that hardware with by project, manufacturing reactor of is further program request coated reactor the modular BWXT small development, NASA supported important fuel. a FY first nuclear demonstration
Virginia shipbuilding there's year new our Second, shipyards class will facilities. in BWXT two the that the could delays, made Navy work we delays recent XX-year significant remind of address a at workload been shipbuilding concurrent in orders around in early procurement handle lot with news plan. to U.S. reflected orders Navy's shipbuilding carrier investments per and you ramp the ensure changes Columbia associated in schedules class To with flow serial and through the the I going
schedules. part, navigated to labor have work most post-COVID. our the pressures the trade-offs varied somewhat supply continue with issues delays. vigilant tighter of since at execution and during plan updated the as successfully The [ months decoupled ensure ] chain shipyards and Cs the some spoke just reflects For the Accordingly, to our are released ago, Navy remain from times That Day said, priorities. we shipbuilding last X customers stability of with over to we we Investor and and XX-year we mid -- shipbuilding in
carrier and adjustment the to is class of to scale for class given potential meaningful that reactor Ford would not of more But backlog quantities. particularly the work. Navy's BWXT plans Virginia impactful the schedule because aircraft the be While our mixed, are
XXXX new be starting in XXXX procurement in According procured to than CVN will plan, rather rather than XXXX. this XXXX in with advanced XX
year. be 'XX and could BWXT, could extended low this For mean carrier that the another in 'XX
to In procurement Components As with programs. the Naval for class aim submarines. of serial our case, this demand Columbia we other any with and we Propulsion, class [indiscernible] visibility submarines production will potentially are remains Work Virginia Reactors, into cadence extended clear in of and offset Fuel doing XXXX, steady
work work. early, to scope extended increased funding support BWXT possible related facilitization architectural get activity. is including August Additionally, -- potential [indiscernible] for to it received workload still work has use on future Navy an initial that lull while demand, could and engineering carrier ahead
believe While business the set for that cadence XX-year orders year-to-year, to Day Investor of growth at specific laid X% from Propulsion remains the we compound shift any Naval rate of we achievable. X% on ship our out could
nation fleet is the various imperative. security to and changes committed The goals Washington the national supplanted long-term for or under have doubtlessly historically nuclear other administrations its dynamics not
ultimately for in Our developing National nicely. we microreactor phase, and is working finalize office, received and projects highlighting worth as advantage progressing including in radars the requirements It Pele and procurement the full request support critical for one XXXX Lab, strategic increasing the vehicles for we system. fiscal Micro DOE noting funding are to Terrestrial and needed the due the operation needs that capabilities strategic of military the authorization high-powered for that with stable alongside sea the to of applications, are could defense for Pele, technology, Reactor tactical government military both land Idaho for basis Project the power is the remote are and and the a licensing serve bill, electrification at the this basis weapons.
while in to a its and was ramping quarter. growth the nicely Similarly, DRACO was early revenue key contributor in stages,
its build Nuclear with our provides Space Rolls-Royce we allies Beyond Space Power U.K. advanced teaming small their secured Agency expanding in other U.S. for domain. teaming capabilities recently modular franchise beyond into including space, for Missions. contract our which nuclear component This microreactor agreement reactor fuel collaboration applications, and and a and development. the on We this DRACO, continue space through presence expand to agreement and to nuclear increasingly and technologies entered we invest in as a
markets. While strategy the to our microreactor is continue in focused defense on commercial applications, primarily we assess opportunities
of nuclear reactors as along history materialize. and our manufacturing expertise significant dedicated opportunities with us well technical the manufacturing Our footprint, Navy, for position commercial
the In and capabilities accountability. deep scrap in Earlier announced multiyear recycled into we've radiochemical the integrated conversion we Contract to protests re-award our Tank joint venture. captured were a DOE. on And enriched Security incumbent, of venture from year, this XX-year of contract when X-year success National purification our XXXX strengths the a material Downblending Materials, assay, X-year to contract the portfolio technical Disposition the this was [indiscernible] a and by Hanford and DOE by first the to the a XXXX. low processing, April in BWXT-led high In BWXT-led based building after uranium joint Special awarded contract extension Complex decided a contract and we contract assembled uranium. a awarded March, handling We on multiple
evidenced While as it is superior again selected being protested, we by our delivered twice. a proposal being
favor, Assuming contract it transition this settles expect year. our in later we the
by encouraged demand, remain focused our operations. are market keenly While on also we we improving
way of of tasked doubled this As improved focus program across requires In and with workforce we've a to to our business. and of as metrics is our quarter, first immense drilling, is before, investments benefits offset improving saw on drive made [indiscernible] sites. our in the helping precision, efficiency we how work to This I process track. our key one the profitability just By nearly team OpEx discussed efficiency continue operational equipment impacts effectiveness the significant inflationary example realize we example, of the facilities.
our Commercial segment. Turning Operations now to
in and medical driven trend, demand XX%. growth Continuing recent the by in Revenue EBITDA was increasing contribution. a the segment isotopes grew EBITDA improved for quarter medical and X% adjusted up was
life announced described growing is a commercial and a the OPG in for full into proceed power the In North project the on release that our Pressure As that January, remains and Hitachi years extension substantial as more working we site Ontario XXXX. earlier set backlog X GE At the drive visibility of in began growth region of Pickering backlog life anticipate is with consider in America the in This of end SMR award I building for the BWXT will formally or call, work SMRs opportunity Generation are BWRX-XXX of demand. Reactor and market manufacturing provide Vessel to strong. revenue the through with extension months. electricity X. opportunity with utilities meet will market, that and in in enticing of another And Europe demand XX nuclear Power units that coming it the our the
as I improves nuclear position our that of in equipment Cambridge at expansion America. The supplier North earlier large preeminent the described
Turning base drug from manufacturing grew on the rapidly, last to BWXT Medical. momentum expansion. with building and diagnostics Revenue year contract
with rapid revenue for Demand development Therapeutic the announcement XX%. leader therapeutic Fusion space expect to diagnostic about Isotopes in Pharmaceuticals billion. of to a continued year full continue $X.X BWXT of Medical and growth AstraZeneca's a acquire and up Actinium-based of for We is partner key to increasing consolidation drug and
data radiopharmaceuticals clinical in these addressable There for trials points growth market. We continue using Actinium isotopes. are drugs clinical positive see significant lutetium and active trials, as over XXX driving the to various advance through
already to have that drugs evolving Some proven successful. be
$X billion the seek announced patient open will for growth market. post-chemotherapy set, the drug of use For Pluvicto only settings is larger annual it cancer significantly highlighting approval would over and in example, market-leading Pluvicto the Novartis that prostate Approval for recently setting. in meaningful this approved sales with lutetium-based currently potential is pre-chemotherapy a
supplier are lutetium currently finalize trials the non-carrier-added to drug our the and year and multiple commercial We of file are ramp only Actinium significantly as master we clinical next commercial sales of plan FDA. supporting with
had positions in multiple and our of guidance. we is reaffirming forefront overall, are occupying the quarter nuclear markets. the XXXX a competitive So at industry good BWXT meaningful
tailwinds We variability. secular are near-term portfolio withstand and over the a demand long funding that term experiencing and can
a these investments. manufacturing, processing services have are world-class unique in workforce, infrastructure highly We enhancing and capabilities credentialed and experienced organic with and
us and to other critical missions the now Rob. security, financial our global to to medium-term to targets. that, address We turn nuclear are well will our customers With oncology I call over positioning energy providing clean nuclear in applications, committed interventional solutions achieve